Analyst Ratings for Century Therapeutics (IPSC)
IPSC Rating Summary
IPSC Price Target Summary
- Highest: $24.00 (Canaccord Genuity)
- Lowest: $4.00 (Piper Sandler)
- Average: $10.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.50 (+1650%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
Avg. $ Target:
$10.50 (+1650%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/13/2024 | Clear Street | Bill Maughan | New Coverage | Buy (N/A) |
9.00 (N/A) |
1.35 (0.60) |
-55.56% | Details |
| 8/8/2024 | Rodman & Renshaw | N/A | New Coverage | Buy (N/A) |
N/A (N/A) |
1.73 (0.60) |
-65.32% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
